News Release

フィジカルAIを活用した「ヒューマノイド開発プロジェクト」を始動

奈良市鴻ノ池運動公園のネーミングライツスポンサー契約締結に関するお知らせ

愛知県大府市で小児近視の実態を調査。保護者の約9割が対策意向も、実行は約5割

日本唯一の子どもの目の炎症に着目したBTA処方を採用「ロートアイビジョン」新発売

New product launch: "V Rohto Dryguard Premium," an over-the-counter eye drop containing 1% high-molecular-weight chondroitin.

The long-loved "Rohto Pharmaceutical corporate commercial song" has been reborn with an arrangement by world-renowned pianist Hayato Sumino and has begun airing as a time signal in the city.

Kyoto Prefecture's Kizugawa City and Rohto Pharmaceutical Co., Ltd. have signed an agreement regarding the provision of temporary evacuation shelters during disasters.

A wearable medical device for managing symptoms of overactive bladder is set to be launched in the Chinese market.

Elucidation of the involvement of chondroitin sulfate in age-related inflammation of the cornea and conjunctiva

Certified as a "Certified Health & Productivity Management Outstanding Organization (White 500)" for the 9th time in 6 consecutive years